SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
This Quarter Return
+23.14%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$508M
AUM Growth
+$508M
(+24%)
Cap. Flow
+$13.3M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
92.34%
Holding
20
New
–
Increased
10
Reduced
1
Closed
1
Top Buys
| 1 |
Samsara
IOT
|
$7.36M |
| 2 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
$6.79M |
| 3 |
monday.com
MNDY
|
$2.65M |
| 4 |
Klaviyo
KVYO
|
$2.4M |
| 5 |
Coupang
CPNG
|
$166K |
Top Sells
| 1 |
UiPath
PATH
|
$4.08M |
| 2 |
Toast
TOST
|
$2.39M |
Sector Composition
| 1 | Technology | 37.55% |
| 2 | Consumer Discretionary | 23.51% |
| 3 | Healthcare | 19.55% |
| 4 | Financials | 19.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Klaviyo
KVYO
$9.73B
| $118M | 23.24% | 3,515,065 +71,550 | +2% | +$2.4M |
|
2
Nu Holdings
NU
$71.5B
| $98.4M | 19.39% | 7,175,434 +11,079 | +0.2% | +$152K |
|
3
DoorDash
DASH
$105B
| $94M | 18.5% | 381,202 +498 | +0.1% | +$123K |
|
|
BBNX
4
Beta Bionics, Inc. Common Stock
BBNX
$819M
| $52M | 10.24% | 3,570,113 +466,331 | +15% | +$6.79M |
|
|
5
Coupang
CPNG
$52.1B
| $25.4M | 5.01% | 849,031 +5,555 | +0.7% | +$166K |
|
6
Inhibikase Therapeutics
IKT
$134M
| $21.4M | 4.2% | 10,950,000 | – | – |
|
|
7
monday.com
MNDY
$9.95B
| $18.3M | 3.61% | 58,336 +8,428 | +17% | +$2.65M |
|
|
8
Samsara
IOT
$20.6B
| $17.4M | 3.43% | 438,485 +185,053 | +73% | +$7.36M |
|
9
Datadog
DDOG
$47.7B
| $15.9M | 3.14% | 118,707 +777 | +0.7% | +$104K |
|
10
CrowdStrike
CRWD
$106B
| $7.95M | 1.57% | 15,615 +55 | +0.4% | +$28K |
|
|
11
Toast
TOST
$26.3B
| $6.94M | 1.37% | 156,604 -54,007 | -26% | -$2.39M |
|
12
Tarsus Pharmaceuticals
TARS
$2.47B
| $6.89M | 1.36% | 170,000 | – | – |
|
13
Snowflake
SNOW
$79.6B
| $6.04M | 1.19% | 27,005 +177 | +0.7% | +$39.6K |
|
14
10x Genomics
TXG
$1.74B
| $5.58M | 1.1% | 481,770 | – | – |
|
15
Acumen Pharmaceuticals
ABOS
$82.4M
| $3.96M | 0.78% | 3,417,075 | – | – |
|
|
BIOA
16
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $3.25M | 0.64% | 786,353 | – | – |
|
17
Acrivon Therapeutics
ACRV
$42.2M
| $2.53M | 0.5% | 2,122,605 | – | – |
|
18
Candel Therapeutics
CADL
$318M
| $2.05M | 0.4% | 405,837 | – | – |
|
19
Taysha Gene Therapies
TSHA
$797M
| $1.67M | 0.33% | 724,873 | – | – |
|
|
20
UiPath
PATH
$5.95B
| – | – | -395,855 | Closed | -$4.08M |
|